Skip to main content
Erschienen in: Journal of Gastroenterology 4/2017

30.05.2016 | Original Article—Alimentary Tract

Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn

verfasst von: Marzio Frazzoni, Nicola de Bortoli, Leonardo Frazzoni, Manuele Furnari, Irene Martinucci, Salvatore Tolone, Andrea Farioli, Santino Marchi, Lorenzo Fuccio, Vincenzo Savarino, Edoardo Savarino

Erschienen in: Journal of Gastroenterology | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Hypersensitive esophagus (HE) is defined by endoscopy-negative heartburn with a normal acid exposure time but positive symptom association probability (SAP) and/or symptom index (SI) on impedance–pH monitoring, and proton pump inhibitor (PPI) responsiveness. Functional heartburn (FH) is distinguished by negative SAP/SI and PPI refractoriness. The clinical value of SAP and SI has been questioned. We aimed to investigate whether impairment of chemical clearance and of mucosal integrity, expressed by the postreflux swallow-induced peristaltic wave (PSPW) index and the mean nocturnal baseline impedance (MNBI), characterize HE independently of SAP and SI.

Methods

Impedance–pH tracings from PPI-responsive endoscopy-negative patients, 125 with nonerosive reflux disease and 108 with HE, distinguished by an abnormal and a normal acid exposure time, and from 70 patients with FH were retrospectively selected and blindly reviewed.

Results

The mean PSPW index and MNBI were significantly lower in nonerosive reflux disease (30 %, 1378 Ω) than in HE (51 %; 2274 Ω) and in both of them as compared with FH (76 %; 3445 Ω) (P = 0.0001). Both the PSPW index (adjusted odds ratio 0.863, P = 0.001) and the MNBI (adjusted odds ratio 0.998, P = 0.001) were independent predictors of HE; with their combined assessment, the area under the curve on receiver operating characteristic analysis was 0.957. SAP and/or SI was positive in 67 of the 108 HE patients (62 %), whereas the PSPW index and/or MNBI was abnormal in 99 of the 108 HE patients (92 %; P < 0.0001).

Conclusions

HE is characterized by impairment of chemical clearance and mucosal integrity, which explains the increased reflux perception. When SAP and SI afford uncertain results, the PSPW index and MNBI should be analyzed.
Literatur
1.
Zurück zum Zitat Galmiche JP, Clouse RE, Balint A, et al. Functional esophageal disorders. Gastroenterology. 2006;130:1459–65.CrossRefPubMed Galmiche JP, Clouse RE, Balint A, et al. Functional esophageal disorders. Gastroenterology. 2006;130:1459–65.CrossRefPubMed
2.
Zurück zum Zitat Katz P, Gerson L, Vela M. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108:308–28.CrossRefPubMed Katz P, Gerson L, Vela M. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108:308–28.CrossRefPubMed
3.
Zurück zum Zitat Zerbib F, Sifrim D, Tutuian R, et al. Modern medical and surgical management of difficult-to-treat GORD. United Eur Gastroenterol J. 2013;1:21–31.CrossRef Zerbib F, Sifrim D, Tutuian R, et al. Modern medical and surgical management of difficult-to-treat GORD. United Eur Gastroenterol J. 2013;1:21–31.CrossRef
4.
Zurück zum Zitat Savarino E, Zentilin P, Savarino V. NERD: an umbrella term including heterogeneous subpopulations. Nat Rev Gastroenterol Hepatol. 2013;10:371–80.CrossRefPubMed Savarino E, Zentilin P, Savarino V. NERD: an umbrella term including heterogeneous subpopulations. Nat Rev Gastroenterol Hepatol. 2013;10:371–80.CrossRefPubMed
5.
Zurück zum Zitat Slaughter JC, Goutte M, Rymer JA, et al. Caution about overinterpretation of symptom indexes in reflux monitoring for refractory gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2011;9:868–74.CrossRefPubMed Slaughter JC, Goutte M, Rymer JA, et al. Caution about overinterpretation of symptom indexes in reflux monitoring for refractory gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2011;9:868–74.CrossRefPubMed
6.
Zurück zum Zitat Vaezi MF. Ambulatory monitoring for gastroesophageal reflux disease: where do we stand? Clin Gastroenterol Hepatol. 2015;13:892–4.CrossRefPubMed Vaezi MF. Ambulatory monitoring for gastroesophageal reflux disease: where do we stand? Clin Gastroenterol Hepatol. 2015;13:892–4.CrossRefPubMed
7.
Zurück zum Zitat Conchillo J, Smout A. Review article: intra-oesophageal impedance monitoring for the assessment of bolus transit and gastro-oesophageal reflux. Aliment Pharmacol Ther. 2008;29:3–14.CrossRefPubMed Conchillo J, Smout A. Review article: intra-oesophageal impedance monitoring for the assessment of bolus transit and gastro-oesophageal reflux. Aliment Pharmacol Ther. 2008;29:3–14.CrossRefPubMed
8.
Zurück zum Zitat Woodley FW, Fernandez F, Mousa H. Diurnal variation in the chemical clearance of acid gastroesophageal reflux in infants. Clin Gastroenterol Hepatol. 2007;5:37–43.CrossRefPubMed Woodley FW, Fernandez F, Mousa H. Diurnal variation in the chemical clearance of acid gastroesophageal reflux in infants. Clin Gastroenterol Hepatol. 2007;5:37–43.CrossRefPubMed
9.
Zurück zum Zitat Frazzoni M, Manta R, Mirante VG, et al. Esophageal chemical clearance is impaired in gastro-oesophageal reflux disease—a 24 h impedance-pH monitoring assessment. Neurogastroenterol Motil. 2013;25:399–406.CrossRefPubMed Frazzoni M, Manta R, Mirante VG, et al. Esophageal chemical clearance is impaired in gastro-oesophageal reflux disease—a 24 h impedance-pH monitoring assessment. Neurogastroenterol Motil. 2013;25:399–406.CrossRefPubMed
10.
Zurück zum Zitat Kessing BF, Bredenoord AJ, Weijenborg PW, et al. Esophageal acid exposure decreases intraluminal baseline impedance. Am J Gastroenterol. 2011;106:2093–7.CrossRefPubMed Kessing BF, Bredenoord AJ, Weijenborg PW, et al. Esophageal acid exposure decreases intraluminal baseline impedance. Am J Gastroenterol. 2011;106:2093–7.CrossRefPubMed
11.
Zurück zum Zitat Farrè R, Blondeau K, Clement D, et al. Evaluation of oesophageal mucosa integrity by the intraluminal impedance technique. Gut. 2011;60:885–92.CrossRefPubMed Farrè R, Blondeau K, Clement D, et al. Evaluation of oesophageal mucosa integrity by the intraluminal impedance technique. Gut. 2011;60:885–92.CrossRefPubMed
12.
Zurück zum Zitat Woodland P, Al-Zinaty M, Yazaki E, et al. In vivo evaluation of acid-induced changes in oesophageal mucosa integrity and sensitivity in non-erosive reflux disease. Gut. 2013;62:1256–61.CrossRefPubMed Woodland P, Al-Zinaty M, Yazaki E, et al. In vivo evaluation of acid-induced changes in oesophageal mucosa integrity and sensitivity in non-erosive reflux disease. Gut. 2013;62:1256–61.CrossRefPubMed
13.
Zurück zum Zitat Farrè R. Pathophysiology of gastro-esophageal reflux disease: a role for mucosa integrity? Neurogastroenterol Motil. 2013;25:783–99.PubMed Farrè R. Pathophysiology of gastro-esophageal reflux disease: a role for mucosa integrity? Neurogastroenterol Motil. 2013;25:783–99.PubMed
14.
Zurück zum Zitat Martinucci I, De Bortoli N, Savarino E, et al. Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn. Neurogastroenterol Motil. 2014;26:546–55.CrossRefPubMed Martinucci I, De Bortoli N, Savarino E, et al. Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn. Neurogastroenterol Motil. 2014;26:546–55.CrossRefPubMed
15.
Zurück zum Zitat De Bortoli N, Martinucci I, Savarino E, et al. Association between baseline impedance values and response proton pump inhibitors in patients with heartburn. Clin Gastroenterol Hepatol. 2015;13:1082–8.CrossRefPubMed De Bortoli N, Martinucci I, Savarino E, et al. Association between baseline impedance values and response proton pump inhibitors in patients with heartburn. Clin Gastroenterol Hepatol. 2015;13:1082–8.CrossRefPubMed
16.
Zurück zum Zitat Frazzoni M, Savarino E, De Bortoli N, et al. Analyses of the post-reflux swallow-induced peristaltic wave index and nocturnal baseline impedance parameters increase the diagnostic yield of patients with reflux disease. Clin Gastroenterol Hepatol. 2016;14:40–6.CrossRefPubMed Frazzoni M, Savarino E, De Bortoli N, et al. Analyses of the post-reflux swallow-induced peristaltic wave index and nocturnal baseline impedance parameters increase the diagnostic yield of patients with reflux disease. Clin Gastroenterol Hepatol. 2016;14:40–6.CrossRefPubMed
17.
Zurück zum Zitat Savarino E, Pohl D, Zentilin P, et al. Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease. Gut. 2009;58:1185–91.CrossRefPubMedPubMedCentral Savarino E, Pohl D, Zentilin P, et al. Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease. Gut. 2009;58:1185–91.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Frazzoni M, Conigliaro R, Manta R, et al. Reflux parameters as modified by EsophyX or laparoscopic fundoplication in refractory GERD. Aliment Pharmacol Ther. 2011;34:67–75.CrossRefPubMed Frazzoni M, Conigliaro R, Manta R, et al. Reflux parameters as modified by EsophyX or laparoscopic fundoplication in refractory GERD. Aliment Pharmacol Ther. 2011;34:67–75.CrossRefPubMed
19.
Zurück zum Zitat Savarino E, Tutuian R, Zentilin P, et al. Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy. Am J Gastroenterol. 2010;105:1053–61.CrossRefPubMed Savarino E, Tutuian R, Zentilin P, et al. Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy. Am J Gastroenterol. 2010;105:1053–61.CrossRefPubMed
20.
Zurück zum Zitat Penagini R, Sweis R, Mauro A, et al. Inconsistency in the diagnosis of functional heartburn: usefulness of prolonged wireless pH monitoring in patients with proton pump inhibitor refractory gastroesophageal reflux disease. J Neurogastroenterol Motil. 2015;21:265–72.CrossRefPubMedPubMedCentral Penagini R, Sweis R, Mauro A, et al. Inconsistency in the diagnosis of functional heartburn: usefulness of prolonged wireless pH monitoring in patients with proton pump inhibitor refractory gastroesophageal reflux disease. J Neurogastroenterol Motil. 2015;21:265–72.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Zerbib F, Roman S, Alpert A, et al. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am J Gastroenterol. 2006;101:1956–63.CrossRefPubMed Zerbib F, Roman S, Alpert A, et al. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am J Gastroenterol. 2006;101:1956–63.CrossRefPubMed
22.
Zurück zum Zitat Savarino E, Zentilin P, Mastracci L, et al. Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn. J Gastroenterol. 2013;48:473–82.CrossRefPubMed Savarino E, Zentilin P, Mastracci L, et al. Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn. J Gastroenterol. 2013;48:473–82.CrossRefPubMed
23.
Zurück zum Zitat Bredenoord AJ, Smout AJPM. Association between reflux and symptoms during ambulatory reflux monitoring: pros and cons of existing methods. Neurogastroenterol Motil. 2013;25:633–7.CrossRefPubMed Bredenoord AJ, Smout AJPM. Association between reflux and symptoms during ambulatory reflux monitoring: pros and cons of existing methods. Neurogastroenterol Motil. 2013;25:633–7.CrossRefPubMed
24.
Zurück zum Zitat Cheng F-K, Albert D, Maydonovitch C, et al. Categorization of patients with reflux symptoms referred for pH and impedance testing while off therapy. Clin Gastroenterol Hepatol. 2015;13:867–73.CrossRefPubMed Cheng F-K, Albert D, Maydonovitch C, et al. Categorization of patients with reflux symptoms referred for pH and impedance testing while off therapy. Clin Gastroenterol Hepatol. 2015;13:867–73.CrossRefPubMed
25.
Zurück zum Zitat Patel A, Sayuk GS, Gyawali P. Parameters on esophageal pH-impedance monitoring that predict outcomes of patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2015;13:884–91.CrossRefPubMed Patel A, Sayuk GS, Gyawali P. Parameters on esophageal pH-impedance monitoring that predict outcomes of patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2015;13:884–91.CrossRefPubMed
26.
Zurück zum Zitat Patel A, Sayuk G, Kushnir V, et al. GERD phenotypes from pH-impedance monitoring predict symptomatic outcomes on prospective evaluation. Neurogastroenterol Motil. 2016;28:513–21.CrossRefPubMed Patel A, Sayuk G, Kushnir V, et al. GERD phenotypes from pH-impedance monitoring predict symptomatic outcomes on prospective evaluation. Neurogastroenterol Motil. 2016;28:513–21.CrossRefPubMed
27.
Zurück zum Zitat Pritchett JM, Aslam M, Slaughter JC, et al. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy. Clin Gastroenterol Hepatol. 2009;7:743–8.CrossRefPubMed Pritchett JM, Aslam M, Slaughter JC, et al. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy. Clin Gastroenterol Hepatol. 2009;7:743–8.CrossRefPubMed
28.
Zurück zum Zitat Frazzoni M, Conigliaro R, Melotti G. Reflux parameters as modified by laparoscopic fundoplication in 40 patients with heartburn/regurgitation persisting despite PPI therapy. A study using impedance-pH monitoring. Dig Dis Sci. 2011;56:1099–106.CrossRefPubMed Frazzoni M, Conigliaro R, Melotti G. Reflux parameters as modified by laparoscopic fundoplication in 40 patients with heartburn/regurgitation persisting despite PPI therapy. A study using impedance-pH monitoring. Dig Dis Sci. 2011;56:1099–106.CrossRefPubMed
29.
Zurück zum Zitat Frazzoni M, Conigliaro R, Mirante VG, et al. The added value of quantitative analysis of on-therapy impedance-pH parameters in distinguishing refractory non-erosive reflux disease from functional heartburn. Neurogastroenterol Motil. 2012;24:141–7.CrossRefPubMed Frazzoni M, Conigliaro R, Mirante VG, et al. The added value of quantitative analysis of on-therapy impedance-pH parameters in distinguishing refractory non-erosive reflux disease from functional heartburn. Neurogastroenterol Motil. 2012;24:141–7.CrossRefPubMed
30.
Zurück zum Zitat Frazzoni M, Piccoli M, Conigliaro R, et al. Refractory gastroesophageal reflux disease as diagnosed by impedance-pH monitoring can be cured by laparoscopic fundoplication. Surg Endosc. 2013;27:2940–6.CrossRefPubMed Frazzoni M, Piccoli M, Conigliaro R, et al. Refractory gastroesophageal reflux disease as diagnosed by impedance-pH monitoring can be cured by laparoscopic fundoplication. Surg Endosc. 2013;27:2940–6.CrossRefPubMed
31.
Zurück zum Zitat De Bortoli N, Martinucci I, Savarino E, et al. Manually calculated oesophageal bolus clearance time increases in parallel with reflux severity at impedance-pH monitoring. Dig Liver Dis. 2015;47:1027–32.CrossRefPubMed De Bortoli N, Martinucci I, Savarino E, et al. Manually calculated oesophageal bolus clearance time increases in parallel with reflux severity at impedance-pH monitoring. Dig Liver Dis. 2015;47:1027–32.CrossRefPubMed
32.
Zurück zum Zitat Frazzoni M, Conigliaro R, Melotti G. Weakly acidic refluxes have a major role in the pathogenesis of proton pump inhibitor-resistant reflux oesophagitis. Aliment Pharmacol Ther. 2011;33:601–6.CrossRefPubMed Frazzoni M, Conigliaro R, Melotti G. Weakly acidic refluxes have a major role in the pathogenesis of proton pump inhibitor-resistant reflux oesophagitis. Aliment Pharmacol Ther. 2011;33:601–6.CrossRefPubMed
33.
Zurück zum Zitat Ribolsi M, Savarino E, De Bortoli N, et al. Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough. Aliment Pharmacol Ther. 2014;40:966–73.CrossRefPubMed Ribolsi M, Savarino E, De Bortoli N, et al. Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough. Aliment Pharmacol Ther. 2014;40:966–73.CrossRefPubMed
34.
Zurück zum Zitat Gyawali CP. Redeeming clinical value of esophageal pH impedance monitoring. Clin Gastroenterol Hepatol. 2016;14:47–9.CrossRefPubMed Gyawali CP. Redeeming clinical value of esophageal pH impedance monitoring. Clin Gastroenterol Hepatol. 2016;14:47–9.CrossRefPubMed
35.
Zurück zum Zitat Numans M, Lau J, de Wit N, et al. Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease—a meta-analysis of diagnostic test characteristics. Ann Intern Med. 2004;140:518–27.CrossRefPubMed Numans M, Lau J, de Wit N, et al. Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease—a meta-analysis of diagnostic test characteristics. Ann Intern Med. 2004;140:518–27.CrossRefPubMed
36.
Zurück zum Zitat Frazzoni M, Bertani H, Manta R, et al. Impairment of chemical clearance is relevant to the pathogenesis of refractory reflux oesophagitis. Dig Liver Dis. 2014;46:596–612.CrossRefPubMed Frazzoni M, Bertani H, Manta R, et al. Impairment of chemical clearance is relevant to the pathogenesis of refractory reflux oesophagitis. Dig Liver Dis. 2014;46:596–612.CrossRefPubMed
37.
Zurück zum Zitat Frazzoni M, Bertani H, Conigliaro R, et al. Neoplastic progression in short-segment Barrett’s oesophagus is associated with impairment of chemical clearance, but not inadequate acid suppression by proton pump inhibitor therapy. Aliment Pharmacol Ther. 2014;40:835–42.CrossRefPubMed Frazzoni M, Bertani H, Conigliaro R, et al. Neoplastic progression in short-segment Barrett’s oesophagus is associated with impairment of chemical clearance, but not inadequate acid suppression by proton pump inhibitor therapy. Aliment Pharmacol Ther. 2014;40:835–42.CrossRefPubMed
38.
Zurück zum Zitat Zerbib F, Roman S, Des Varannes SB, et al. Normal values of pharyngeal and esophageal 24 h pH impedance in individuals on and off therapy and interobserver reproducibility. Clin Gastroenterol Hepatol. 2013;11:366–72.CrossRefPubMed Zerbib F, Roman S, Des Varannes SB, et al. Normal values of pharyngeal and esophageal 24 h pH impedance in individuals on and off therapy and interobserver reproducibility. Clin Gastroenterol Hepatol. 2013;11:366–72.CrossRefPubMed
39.
Zurück zum Zitat Broeders JA, Draaisma WA, Bredenoord AJ, et al. Oesophageal acid hypersensitivity is not a contraindication to Nissen fundoplication. Br J Surg. 2009;96:1023–30.CrossRefPubMed Broeders JA, Draaisma WA, Bredenoord AJ, et al. Oesophageal acid hypersensitivity is not a contraindication to Nissen fundoplication. Br J Surg. 2009;96:1023–30.CrossRefPubMed
40.
Zurück zum Zitat Desjardin M, Luc G, Collet D, et al. 24 h pH-impedance monitoring on therapy to select patients with refractory reflux symptoms for antireflux surgery. A single center retrospective study. Neurogastroenterol Motil. 2016;28:146–52.CrossRefPubMed Desjardin M, Luc G, Collet D, et al. 24 h pH-impedance monitoring on therapy to select patients with refractory reflux symptoms for antireflux surgery. A single center retrospective study. Neurogastroenterol Motil. 2016;28:146–52.CrossRefPubMed
41.
Zurück zum Zitat Roman S, Bruley Des Varannes S, Pouderoux P, et al. Ambulatory 24 h oesophageal impedance–pH recordings: reliability of automatic analysis for gastro-oesophageal reflux assessment. Neurogastroenterol Motil. 2006;18:978–86.CrossRefPubMed Roman S, Bruley Des Varannes S, Pouderoux P, et al. Ambulatory 24 h oesophageal impedance–pH recordings: reliability of automatic analysis for gastro-oesophageal reflux assessment. Neurogastroenterol Motil. 2006;18:978–86.CrossRefPubMed
Metadaten
Titel
Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn
verfasst von
Marzio Frazzoni
Nicola de Bortoli
Leonardo Frazzoni
Manuele Furnari
Irene Martinucci
Salvatore Tolone
Andrea Farioli
Santino Marchi
Lorenzo Fuccio
Vincenzo Savarino
Edoardo Savarino
Publikationsdatum
30.05.2016
Verlag
Springer Japan
Erschienen in
Journal of Gastroenterology / Ausgabe 4/2017
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-016-1226-9

Weitere Artikel der Ausgabe 4/2017

Journal of Gastroenterology 4/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.